Efficacy of Oral BG-12 (Dimethyl Fumarate) in Patients Newly Diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Analysis of DEFINE and CONFIRM

被引：0
|
作者：
Gold, R. [1 ]
Giovannoni, G. [2 ]
Phillips, J. T. [3 ]
Fox, R. J. [4 ]
Rana, J. [5 ]
Zhang, A. [5 ]
Meltzer, L. [5 ]
Kurukulasuriya, N. C. [5 ]
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[5] Biogen Idec Inc, Weston, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-65
引用
收藏
页码：931 / 932
页数：2
相关论文
共 50 条
  • [31] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the DEFINE study
    Amit Bar-Or
    Ralf Gold
    Ludwig Kappos
    Douglas L. Arnold
    Gavin Giovannoni
    Krzysztof Selmaj
    John O’Gorman
    Monica Stephan
    Katherine T. Dawson
    Journal of Neurology, 2013, 260 : 2297 - 2305
  • [32] Safety and Tolerability of BG-12 in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Analyses From the CONFIRM Study
    Phillips, J. Theodore
    Fox, Robert
    Miller, David
    Kita, Mariko
    Hutchinson, Michael
    Havrdova, Eva
    Raghupathi, Kartik
    Yuan, Huixing
    Novas, Mark
    Viglietta, Vissia
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [33] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Havrdova, E.
    Phillips, J. T.
    Fox, R. J.
    Miller, D.
    Kita, M.
    Hutchinson, M.
    Raghupathi, K.
    Yuan, H.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S105
  • [34] Effect of BG-12 (Dimethyl Fumarate) in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: Findings from Two Phase 3 Studies (DEFINE and CONFIRM)
    Hutchinson, M.
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Kita, M.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 682 - 683
  • [35] Clinical Efficacy of BG-12 in Relapsing-Remitting Multiple Sclerosis (RRMS): Data from the Phase 3 CONFIRM Study
    Fox, Robert
    Miller, David
    Phillips, J. Theodore
    Kita, Mariko
    Hutchinson, Michael
    Havrdova, Eva
    Yang, Minhua
    Zhang, Ray
    Viglietta, Vissia
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [36] Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Meltzer, Leslie
    Kurukulasuriya, Nuwan C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 57 - 66
  • [37] Clinical effects of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Kita, M.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 191 - 191
  • [38] Three-year follow-up of oral BG-12 (dimethyl fumarate) treatment in relapsing remitting multiple sclerosis (RRMS): integrated clinical efficacy data from the DEFINE, CONFIRM, and ENDORSE studies
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Hutchinson, M.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 222 - 222
  • [39] Safety and Tolerability of Oral BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis (RRMS): Interim Results from ENDORSE Extension Study
    Phillips, J. Theodore
    Fox, Robert
    Selmaj, Krzysztof
    Raghupathi, Kartik
    Yuan, Huixing
    Novas, Mark
    Sweetser, Marianne
    Viglietta, Vissia
    Dawson, Katherine
    Gold, Ralf
    NEUROLOGY, 2013, 80
  • [40] THE COST EFFECTIVENESS OF BG-12 (DIMETHYL FUMARATE) FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CANADA
    Su, W.
    Walker, A.
    Sarda, S.
    Kansal, A. R.
    Vicente, C.
    Deniz, B.
    VALUE IN HEALTH, 2013, 16 (07) : A623 - A623
12345